← Back to Search

Muscle Relaxant

Not pretreated for Muscle Pain

Phase 3
Waitlist Available
Led By Leighan Bye, MD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 hours and 24 hours post succinylcholine administration
Awards & highlights

Study Summary

This trial is testing whether or not a second medication can reduce muscle soreness caused by the first medication given as part of anesthesia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 hours and 24 hours post succinylcholine administration
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 hours and 24 hours post succinylcholine administration for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Myalgias Perceived at 3 Hours
Myalgias at 24 Hours Post Succinylcholine Administration.
Pain Scores
Secondary outcome measures
Number of Participants With Observed Presence of Muscle Fasciculation Following Succinylcholine Administration

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Not pretreatedExperimental Treatment1 Intervention
Succinylcholine administration with no Rocuronium pre-treatment
Group II: Pre-treated 2 minutes before succinylcholine administratjionActive Control1 Intervention
Succinylcholine administratjion 2 minutes following Rocuronium pre-treatment
Group III: Pre-treated 1 minute before succinylcholine administrationActive Control1 Intervention
Succinylcholine administration 1 minute following Rocuronium pre-treatment

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
993 Previous Clinical Trials
1,094,983 Total Patients Enrolled
Leighan Bye, MDPrincipal InvestigatorIndiana University
~65 spots leftby Jun 2025